Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Academic Unit of Bone Metabolism, University of Sheffield, Sheffield, UK.
Clin Endocrinol (Oxf). 2019 Jan;90(1):222-231. doi: 10.1111/cen.13825. Epub 2018 Sep 9.
It is well established that UK Asians typically have lower vitamin D levels than Caucasians. It is also known that vitamin D binding protein (DBP) is lower in some races than Caucasians. To investigate how ethnicity, skin colour and genetic variation affect the response to vitamin D (15000 IU) administered to young Asian and Caucasian men.
Prospective, single-centre clinical trial.
Sixty young men (18-25 year) of Asian (n = 30) and Caucasian (n = 30) origin.
We measured serum calcium, phosphate, magnesium, alkaline phosphatase, albumin, parathyroid hormone; total 25 hydroxyvitamin D (25OHD); calculated and directly measured free 25OHD; DBP at baseline and 4 weeks; DBP genotype, skin colour (Fitzpatrick scale), dietary vitamin D and calcium intake at baseline; and urine calcium:creatinine ratio at baseline, 1 and 4 weeks.
At baseline, Asians had lower serum total 25OHD (26.4 [13.7] vs 34.1 [12.3] nmol/L P = 0.0272) and DBP (6.7 [3.4] vs 9.6 [4.4] nmol/L; P = 0.0065) but similar free 25OHD (16.7 [10.4] vs 17.8 [7.5] pmol/L P = 0.6530). After dosing, total 25OHD rose similarly in each group (≈56 nmol/L), but measured free 25OHD rose more in Asians (18.1 [9.4] vs 12.2 [13.3] pmol/L P = 0.0464). Lower DBP at baseline, possibly reflecting genotype differences, was associated with a greater change in measured free 25OHD in Caucasians, but not in Asians.
Asian compared with Caucasian males had a larger increment in measured free 25OHD following 150 000 units vitamin D3, possibly reflecting differences in DBP affinity for 25OHD. Ethnicity should be considered when devising guidelines for the treatment of vitamin D deficiency.
众所周知,英国亚洲人通常比白种人维生素 D 水平低。也已知维生素 D 结合蛋白(DBP)在某些种族中比白种人低。研究维生素 D(15000 IU)对年轻亚洲男性和白种人男性的影响,探讨种族、肤色和遗传变异如何影响维生素 D 的反应。
前瞻性、单中心临床试验。
60 名年轻男性(18-25 岁),亚洲人(n=30)和白种人(n=30)。
我们测量血清钙、磷、镁、碱性磷酸酶、白蛋白、甲状旁腺激素;总 25 羟维生素 D(25OHD);计算和直接测量游离 25OHD;DBP 基线和 4 周时;DBP 基因型、肤色(Fitzpatrick 量表)、基线时维生素 D 和钙的饮食摄入;以及基线、1 周和 4 周时尿钙/肌酐比值。
在基线时,亚洲人血清总 25OHD(26.4 [13.7] vs 34.1 [12.3] nmol/L P=0.0272)和 DBP(6.7 [3.4] vs 9.6 [4.4] nmol/L;P=0.0065)较低,但游离 25OHD 相似(16.7 [10.4] vs 17.8 [7.5] pmol/L P=0.6530)。给药后,两组总 25OHD 升高相似(≈56 nmol/L),但亚洲人测量的游离 25OHD 升高更多(18.1 [9.4] vs 12.2 [13.3] pmol/L P=0.0464)。基线时 DBP 较低,可能反映基因型差异,与白种人测量的游离 25OHD 变化相关更大,但亚洲人则不然。
与白种人男性相比,亚洲男性在接受 150000 单位维生素 D3 后,测量的游离 25OHD 增加幅度更大,这可能反映了 DBP 与 25OHD 亲和力的差异。在制定维生素 D 缺乏治疗指南时应考虑种族因素。